Colgate-Palmolive (India) (500830) Q4 01/02 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 01/02 earnings summary
19 Oct, 2026Executive summary
FY02 sales were Rs 1,160.89 crore, described as flat amid a difficult market; net profit rose 12% to Rs 69.79 crore.
Cost reduction, productivity, sales execution and brand initiatives supported improved performance and market-share gains.
Financial highlights
Total revenue was Rs 1,191.84 crore vs Rs 1,206.39 crore; sales were Rs 1,160.89 crore vs Rs 1,176.88 crore.
PBT rose to Rs 114.69 crore from Rs 105.80 crore; PAT reached Rs 69.79 crore vs Rs 62.50 crore.
Consolidated FY02 revenue was Rs 1,188.72 crore, PBT Rs 111.35 crore and PAT Rs 66.25 crore; EPS was Rs 4.87.
Outlook and guidance
Industry outlook was considered positive, with market development and expanded oral-care use expected to support healthy market growth over the next few years.
Future priorities include innovative, high-quality products and continued cost reduction to fund growth.
Latest events from Colgate-Palmolive (India)
- Q2 sales rose 12.2%, gross margin reached 69.6%, and adjusted PAT grew 5.5%.500830
Q2 26/27 - Sales grew 16.5%, but excise-related inventory costs constrained profit growth.500830Q4 96/97
- Sales advanced amid sluggish demand as strategic investments and product launches expanded.500830Q4 97/98
- Profit fell amid weak demand, while product launches and capacity expansion positioned growth.500830Q4 98/99
- Sales rose 12% and adjusted profit 23% despite a depressed FMCG market.500830Q4 99/00
- Profit rose 27% despite falling sales as product renewal offset market headwinds.500830Q4 02/03
- Sales and profit advanced on launches and cash generation despite weak demand.500830Q4 00/01
- Profit rose 22% as price cuts revived toothpaste demand and capacity expansion advanced.500830Q4 03/04
- Sales rose 17%, record profit grew 21%, and Nepal toothpaste production ended.500830Q4 05/06